Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00018-004-4255-0.

Title:
Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines | Cellular and Molecular Life Sciences
Description:
In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies). We report here that injection of naked β-globin untranslated region (UTR)-stabilized mRNA coding for β-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application of recombinant granulocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the requirement of antiviral, antibacterial or antitumor immunity.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Mobile Technology & AI
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, mrna, vaccination, vaccines, access, privacy, cookies, content, data, information, publish, research, search, injection, carralot, probst, pascolo, strategy, rna, log, journal, life, cmls, immunity, naked, hoerr, scheel, genetic, open, discover, author, tübingen, germany, cell, springer, optional, personal, parties, policy, find, track, cellular, molecular, sciences, polarization, induced, direct, sequencestabilized, cite, teufel,

Topics {✒️}

th1-type immune response globin utr-stabilized mrna month download article/chapter long-term uncontrolled expression anti-dna antibodies mrna vaccines stabilized mrna coding related subjects genetic vaccination privacy choices/manage cookies dna vaccination full article pdf vaccination strategy primes versatile vaccination strategy european economic area scope submit manuscript check access author correspondence instant access conditions privacy policy accepting optional cookies article cellular main content log vaccination strategy journal finder publish cell biology th2 article log life sci mrna vaccine article cite mrna injection article carralot privacy policy personal data β-galactosidase books a cell information optional cookies manage preferences essential cookies cookies skip subscription content similar content data protection data demonstrate pascolo institute institution subscribe journal publish

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines
         description:In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies). We report here that injection of naked β-globin untranslated region (UTR)-stabilized mRNA coding for β-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application of recombinant granulocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the requirement of antiviral, antibacterial or antitumor immunity.
         datePublished:
         dateModified:
         pageStart:2418
         pageEnd:2424
         sameAs:https://doi.org/10.1007/s00018-004-4255-0
         keywords:
            Vaccination
            Th1/Th2 cell
            rodent
            gene therapy
            messenger RNA
            GM-CSF
            Cell Biology
            Biomedicine
            general
            Life Sciences
            Biochemistry
         image:
         isPartOf:
            name:Cellular and Molecular Life Sciences CMLS
            issn:
               1420-9071
               1420-682X
            volumeNumber:61
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Birkhäuser-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:J.-P. Carralot
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
                     name:Department of Immunology
                     address:
                        name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Probst
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
                     name:Department of Immunology
                     address:
                        name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. Hoerr
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. Scheel
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
                     name:Department of Immunology
                     address:
                        name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Teufel
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Jung
               affiliation:
                     name:Institute of Organic Chemistry
                     address:
                        name:Institute of Organic Chemistry, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H.-G. Rammensee
               affiliation:
                     name:Department of Immunology
                     address:
                        name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Pascolo
               affiliation:
                     name:CureVac GmbH
                     address:
                        name:CureVac GmbH, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
                     name:Department of Immunology
                     address:
                        name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines
      description:In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies). We report here that injection of naked β-globin untranslated region (UTR)-stabilized mRNA coding for β-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application of recombinant granulocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the requirement of antiviral, antibacterial or antitumor immunity.
      datePublished:
      dateModified:
      pageStart:2418
      pageEnd:2424
      sameAs:https://doi.org/10.1007/s00018-004-4255-0
      keywords:
         Vaccination
         Th1/Th2 cell
         rodent
         gene therapy
         messenger RNA
         GM-CSF
         Cell Biology
         Biomedicine
         general
         Life Sciences
         Biochemistry
      image:
      isPartOf:
         name:Cellular and Molecular Life Sciences CMLS
         issn:
            1420-9071
            1420-682X
         volumeNumber:61
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Birkhäuser-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:J.-P. Carralot
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
                  name:Department of Immunology
                  address:
                     name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Probst
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
                  name:Department of Immunology
                  address:
                     name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. Hoerr
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. Scheel
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
                  name:Department of Immunology
                  address:
                     name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Teufel
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Jung
            affiliation:
                  name:Institute of Organic Chemistry
                  address:
                     name:Institute of Organic Chemistry, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H.-G. Rammensee
            affiliation:
                  name:Department of Immunology
                  address:
                     name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Pascolo
            affiliation:
                  name:CureVac GmbH
                  address:
                     name:CureVac GmbH, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
                  name:Department of Immunology
                  address:
                     name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cellular and Molecular Life Sciences CMLS
      issn:
         1420-9071
         1420-682X
      volumeNumber:61
Organization:
      name:Birkhäuser-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tübingen, Germany
         type:PostalAddress
      name:Department of Immunology
      address:
         name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tübingen, Germany
         type:PostalAddress
      name:Department of Immunology
      address:
         name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tübingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tübingen, Germany
         type:PostalAddress
      name:Department of Immunology
      address:
         name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tübingen, Germany
         type:PostalAddress
      name:Institute of Organic Chemistry
      address:
         name:Institute of Organic Chemistry, Tübingen, Germany
         type:PostalAddress
      name:Department of Immunology
      address:
         name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
         type:PostalAddress
      name:CureVac GmbH
      address:
         name:CureVac GmbH, Tübingen, Germany
         type:PostalAddress
      name:Department of Immunology
      address:
         name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:J.-P. Carralot
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tübingen, Germany
               type:PostalAddress
            type:Organization
            name:Department of Immunology
            address:
               name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:J. Probst
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tübingen, Germany
               type:PostalAddress
            type:Organization
            name:Department of Immunology
            address:
               name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:I. Hoerr
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:B. Scheel
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tübingen, Germany
               type:PostalAddress
            type:Organization
            name:Department of Immunology
            address:
               name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:R. Teufel
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:G. Jung
      affiliation:
            name:Institute of Organic Chemistry
            address:
               name:Institute of Organic Chemistry, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:H.-G. Rammensee
      affiliation:
            name:Department of Immunology
            address:
               name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
               type:PostalAddress
            type:Organization
      name:S. Pascolo
      affiliation:
            name:CureVac GmbH
            address:
               name:CureVac GmbH, Tübingen, Germany
               type:PostalAddress
            type:Organization
            name:Department of Immunology
            address:
               name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:CureVac GmbH, Tübingen, Germany
      name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
      name:CureVac GmbH, Tübingen, Germany
      name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
      name:CureVac GmbH, Tübingen, Germany
      name:CureVac GmbH, Tübingen, Germany
      name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
      name:CureVac GmbH, Tübingen, Germany
      name:Institute of Organic Chemistry, Tübingen, Germany
      name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
      name:CureVac GmbH, Tübingen, Germany
      name:Institute for Cell Biology, Department of Immunology, Tübingen, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(39)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.58s.